We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current ALDVI market cap is 17.88M. The company's latest EPS is EUR -0.7078 and P/E is -2.54.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 2.58M | 3.57M | 3.77M | 3.07M | 3.48M |
| Operating Income | -14.25M | -14.14M | -12.44M | -10.06M | -6.46M |
| Net Income | -14.2M | -14.85M | -12.43M | -11.47M | -7.03M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 23.88M | 24M | 18.88M | 14.26M | 12.41M |
| Total Liabilities | 7.16M | 20.73M | 18.57M | 24.88M | 24.38M |
| Total Equity | 16.72M | 3.27M | 309k | -10.62M | -11.97M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | -9.48M | -11.69M | -12.53M | -9.15M | -5.99M |
| Investing | -1.11M | -694k | -451k | -2k | -1.32M |
| Financing | 984k | 12.53M | 8.91M | 4.78M | 4.23M |
| Market Cap | 17.88M |
| Price to Earnings Ratio | -2.54 |
| Price to Sales Ratio | 5.13 |
| Price to Cash Ratio | 3.41 |
| Price to Book Ratio | -1.49 |
| Dividend Yield | - |
| Shares Outstanding | 9.93M |
| Average Volume (1 week) | 24k |
| Average Volume (1 Month) | 27.85k |
| 52 Week Change | -51.22% |
| 52 Week High | 4.40 |
| 52 Week Low | 1.10 |
| Spread (Intraday) | 0.01 (0.66%) |
| Company Name | Advicenne |
| Address |
262, rue du faubourg paris, paris 75008 |
| Website | https://www.advicenne.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
